Milestone Pharmaceuticals Inc.
MIST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001408443
No open-market purchases or sales by Milestone Pharmaceuticals Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Milestone Pharmaceuticals Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 39 | 40 | +1 |
| Shares | 19.6M | 17.8M | −1.77M (−9.0%) |
| Value | $60.7M | $29.7M | −$30.9M (−51.0%) |
New holders (8)
Institutions that held Milestone Pharmaceuticals Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ancora Advisors, LLC | 50,000 | $83.5K | 0.00% |
| Northern Trust Corp | 31,970 | $53.4K | 0.00% |
| Group One Trading, L.P. | 20,762 | $34.7K | 0.00% |
| Virtu Financial LLC | 18,686 | $31.0K | 0.00% |
| Susquehanna International Group, LLP | 13,299 | $22.2K | 0.00% |
| Engineers Gate Manager LP | 13,135 | $21.9K | 0.00% |
| Simplex Trading, LLC | 1,086 | $1.00K | 0.00% |
| ICA Group Wealth Management, LLC | 200 | $334 | 0.00% |
Sold out (7)
Institutions that held Milestone Pharmaceuticals Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Affinity Asset Advisors, LLC | 335,068 | $1.04M |
| Marshall Wace, LLP | 113,187 | $350.9K |
| Gsa Capital Partners LLP | 48,796 | $151.0K |
| Squarepoint Ops LLC | 41,109 | $127.4K |
| LMR Partners LLP | 38,495 | $119.3K |
| Bank of America Corp | 1,955 | $6.06K |
| UBS Group AG | 1,693 | $5.25K |